News Column

EXELIXIS, INC. FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits

January 23, 2014

Item 8.01 Other Events. On January 23, 2014 , Exelixis, Inc. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with Cowen and Company, LLC (the "Underwriter") relating to the offering, issuance and sale (the "Offering") of 10,000,000 shares of the Company's common stock, par value $0.001 per share. Pursuant to the Underwriting Agreement, the Underwriter has agreed to purchase the shares of common stock from the Company at a price of $7.60 per share, which will result in $76.0 million of proceeds to the Company before deducting offering expenses. The offering is expected to close on or about January 28, 2014 , subject to customary closing conditions. The shares of common stock will be listed on The NASDAQ Global Select Market. The Underwriter has a 30-day option to purchase up to an additional 1,500,000 shares of common stock. All of the shares in the offering are being sold by the Company. The Offering is being made pursuant to the Company's effective shelf registration statement on Form S-3 (Registration No. 333-182018) previously filed with the Securities and Exchange Commission (the "SEC"). The Company has filed a final prospectus supplement, dated January 23, 2014 , relating to the issuance and sale of the shares with the SEC . The Underwriting Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriter, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement and may be subject to limitations agreed upon by the contracting parties. The Underwriting Agreement is filed as Exhibit 1.1 hereto and is incorporated herein by reference. The foregoing description of the terms of the Underwriting Agreement is qualified in its entirety by reference to such exhibit. A copy of the opinion of Cooley LLP relating to the legality of the issuance and sale of the shares in the offering is attached as Exhibit 5.1 hereto. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 Underwriting Agreement, dated January 23, 2014 5.1 Opinion of Cooley LLP 23.1 Consent of Cooley LLP (contained in Exhibit 5.1) --------------------------------------------------------------------------------

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools